Generating and weighing evidence in drug development and regulatory decision making: 5th US FDA-DIA workshop on pharmacogenomics.
about
Clinical implementation of genetic testing in medicine: a US regulatory science perspective.The role of ADME pharmacogenomics in early clinical trials: perspective of the Industry Pharmacogenomics Working Group (I-PWG).Applications of pharmacogenomics in regulatory science: a product life cycle review.
P2860
Generating and weighing evidence in drug development and regulatory decision making: 5th US FDA-DIA workshop on pharmacogenomics.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Generating and weighing eviden ...... workshop on pharmacogenomics.
@en
Generating and weighing eviden ...... workshop on pharmacogenomics.
@nl
type
label
Generating and weighing eviden ...... workshop on pharmacogenomics.
@en
Generating and weighing eviden ...... workshop on pharmacogenomics.
@nl
prefLabel
Generating and weighing eviden ...... workshop on pharmacogenomics.
@en
Generating and weighing eviden ...... workshop on pharmacogenomics.
@nl
P356
P1433
P1476
Generating and weighing eviden ...... workshop on pharmacogenomics.
@en
P2093
Issam Zineh
Peter M Shaw
P2860
P304
P356
10.2217/PGS.10.142
P577
2010-12-01T00:00:00Z